Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
10/2013
10/17/2013US20130274263 Tubulin inhibitors
10/17/2013US20130274255 Heterocyclic pyrazole compounds, method for preparing the same and use thereof
10/17/2013US20130274208 Small Peptides And Methods For Treatment Of Chronic Inflammatory Bowel Disease
10/17/2013US20130273042 Treatment of multiple sclerosis
10/17/2013US20130273041 Use of chimeric anti-cd20 antibody as in vitro or in vivo purging agent in patients receiving bmt or pbsc transplant
10/17/2013US20130273009 Methods to mobilize progenitor/stem cells
10/17/2013US20130273001 Immunostimulation by chemically modified rna
10/17/2013US20130272997 Synthetic mechanical hemostatic composition, method of making and use thereof
10/17/2013US20130272964 Molecules with extended half-lives, compositions and uses thereof
10/16/2013EP2650361A1 Galectin 9-secreting cell, production method for same, and application for same
10/16/2013EP2650309A1 Conjugate of folate and antibody, preparation method and use thereof
10/16/2013EP2650008A1 Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of various cardiovascular diseases
10/16/2013EP2650007A1 Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of various cardiovascular diseases
10/16/2013EP2650002A1 Bifidobacterium cect 7765 and use thereof in the prevention and/or treatment of excess weight, obesity and related pathologies
10/16/2013EP2649992A1 New pharmaceutic use of benzoic aicd derivatives
10/16/2013EP2649084A1 Novel derivatives of oxazaphosphorines that are pre-activated, use and method of preparation
10/16/2013EP2648737A1 Treating conditions associated with increased eotaxin with 25-hydroxyvitamin d3
10/16/2013EP2648726A1 Polycyclic lpa1 antagonist and uses thereof
10/16/2013EP2648725A1 TREATMENT OF CHRONIC INFLAMMATION WITH A 1,2,4-TRIAZOLO [1,5a]PYRIDINE DERIVATIVE
10/16/2013EP2648516A1 Substituted pyridinone-pyridinyl compounds
10/16/2013EP2648511A1 Pyrazolyl guanidine f1f0-atpase inhibitors and therapeutic uses thereof
10/16/2013EP2399937A9 Anti-human alpha9 integrin antibody and use thereof
10/16/2013CN103354833A Bacterial ribonucleic acid cell wall compositions and methods of making and using them
10/16/2013CN103352037A Aptamer therapeutics useful in the treatment of complement-related disorders
10/16/2013CN103351992A Preparation method of kudzu health wine
10/16/2013CN103351991A Manufacture method of panax notoginseng health wine
10/16/2013CN103351415A Method for preparing salidrosides with a series of purities from glossy privet fruit
10/16/2013CN103351336A Naphthalenecarboxamide derivative as inhibitors of protein kinase and histone deacetylase and preparation method thereof
10/16/2013CN103349777A Crig polypeptide used for prevention and treatment of related disorder of alexin
10/16/2013CN103349738A Traditional Chinese medicinal formula convenient for oral administration and external application of females
10/16/2013CN103349732A Dendrobium officinale kimura et migo-panax quinquefolius buccal tablets for diabetes patients, and preparation method thereof
10/16/2013CN103349711A Anti-aging combination with resveratrol and preparation method thereof
10/16/2013CN103349669A Malic acid-containing composite dialysis preparation and preparation method thereof
10/16/2013CN103349286A Application of fermentation product of paecilomyces cicadae
10/16/2013CN102755512B Traditional Chinese medicine extract capable of improving CIK cell proliferation rate as well as preparation method
10/16/2013CN102742730B Application of herbal substance in preparation of health care forage capable of improving rabbit immunity
10/16/2013CN102727886B Preparation method of immunostimulatory injection for livestock
10/16/2013CN102676396B Paecilomyces tenuipes strain and application thereof
10/16/2013CN102559689B Prawn complement 1q binding protein and application thereof
10/16/2013CN102504026B Full human single chain antibody capable of resisting epidermal growth-factor receptor and application thereof
10/16/2013CN102462723B Tripterygium glycoside-containing micro-emulsified gel transdermal preparation and preparation method thereof
10/16/2013CN102421778B Dihydropteridinone derivatives, preparation process and pharmaceutical use thereof
10/16/2013CN102379962B Traditional Chinese medicine combination for healthcare and treatment of livestock
10/16/2013CN102276727B IL-17RC-hFc fusion protein and application thereof
10/16/2013CN101605905B Method for glycosylation of flavonoid
10/15/2013US8557967 Anti-interferon-α antibodies
10/15/2013US8557806 Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
10/15/2013US8557796 Substituted 1-oxa-2,8-diaza-spiro [4,5] dec-2-ene derivatives and related treatment methods
10/15/2013US8557785 In vivo production of small interfering RNAS that mediate gene silencing
10/15/2013US8557579 Screening for modulators of PSGL-1 with respect to T cell or NK cell death
10/15/2013US8557240 Method for the treatment of inflammatory disorders
10/15/2013US8557233 Probiotic bifidobacterium strains
10/15/2013CA2604327C Pharmaceutical aerosol composition
10/15/2013CA2555013C Carcinoembryonic antigen fusions and uses thereof
10/15/2013CA2494844C Methods and compositions concerning poxviruses and cancer
10/15/2013CA2487732C Cardiac glycosides to treat cystic fibrosis and other il-8 dependent disorders
10/15/2013CA2452119C Polynucleotides encoding antigenic hiv type b and/or type c polypeptides, polypeptides and uses thereof
10/15/2013CA2445655C Drug releasing anastomosis devices and methods for treating anastomotic sites
10/15/2013CA2373721C Compounds that bind her2
10/10/2013WO2013152024A1 Humanized and chimeric anti-factor c3 antibodies and uses thereof
10/10/2013WO2013152020A1 Humanized and chimeric anti-factor bb antibodies and uses thereof
10/10/2013WO2013151999A1 Cancer treatment and immune system regulation through fat10 pathway inhibition
10/10/2013WO2013151930A1 Bicyclic azaheterocyclobenzylamines as pi3k inhibitors
10/10/2013WO2013151595A1 Improved adjuvant system for oral vaccine adminstration
10/10/2013WO2013151490A1 Methods and compounds for treating diseases
10/10/2013WO2013150292A1 Composition for the treatment of inflammatory and immune disorders
10/10/2013WO2013149997A1 Substituted tricyclic compounds with activity towards ep1 receptors
10/10/2013WO2013149996A1 Substituted tricyclic compounds with activity towards ep1 receptors
10/10/2013WO2013149986A1 Use of ccr3-inhibitors
10/10/2013WO2013149334A1 Recombinant papaya mosaic virus coat proteins and uses thereof in influenza vaccines
10/10/2013WO2013097022A3 Recombinant proteins, polynucleotides and vaccines to combat bovine herpesvirus
10/10/2013US20130267713 Hepatitis C Virus Inhibitors
10/10/2013US20130266553 Albumin Fusion Proteins
10/09/2013EP2647645A1 Recombinant proteins of Parapoxvirus ovis and pharmaceutical compositions therefrom
10/09/2013EP2647638A1 Substituted tricyclic compounds with activity towards ep1 receptors
10/09/2013EP2647628A1 Substituted tricyclic compounds with activity towards ep1 receptors
10/09/2013EP2647384A1 IMMUNOTHERAPY USING ALLO-NKT CELLS, CELLS FOR IMMUNOTHERAPY IN WHICH CHAIN OF T-CELL RECEPTOR (TCR) GENE HAS BEEN REARRANGED TO UNIFORM Va-Ja , AND BANKING OF NKT CELLS DERIVED FROM SAID CELLS
10/09/2013EP2647382A1 Compositions and methods for treating epithelial and retinal tissue diseases
10/09/2013EP2647374A1 Nutritional compositions including beta-hydroxy-beta-methylbutyrate for regulating transcription factors
10/09/2013EP2646567A1 Detection of fusobacterium in a gastrointestinal sample to diagnose gastrointestinal cancer
10/09/2013EP2646546A1 Tomm34 peptides and vaccines including the same
10/09/2013EP2646409A1 Fingolimod polymorphs and their processes
10/09/2013CN103348007A Virus like particle production in plant
10/09/2013CN103347860A Nampt抑制剂 Nampt inhibitor
10/09/2013CN103347527A Method for producing innate immunity activator having enhanced innate immunity promoting activity, and royal jelly-derived innate immunity activator which is produced by the production method
10/09/2013CN103347505A Skin collagen production promoter
10/09/2013CN103343078A Production process of golden stichopus japonicus health-care yellow wine
10/09/2013CN103342757A Amphipathic chondroitin sulfate derivative and preparation method and application thereof
10/09/2013CN103342744A Angiogenesis protein and application thereof
10/09/2013CN103341147A Traditional Chinese medicine preparation for treating cold and dampness-clip hot allergic rhinitis and chronic rhinitis
10/09/2013CN103341146A Traditional Chinese medicine preparation for treating cold and dampness type chronic rhinitis
10/09/2013CN103341139A Chinese medicine composition as well as preparation method and use thereof
10/09/2013CN103341039A Nourishing formula for enhancing human body immunity and production method of soup thereof
10/09/2013CN103341011A Chinese medicine composite capable of improving immunity
10/09/2013CN103340982A Wolfberry powder tablet and preparation method thereof
10/09/2013CN103340959A Oldenlandia diffusa essence, as well as preparation method and pharmic application thereof
10/09/2013CN103340919A Lucid ganoderma refined powder compound soft capsule and preparation method thereof
10/09/2013CN103340896A Duplex dentin hypersensitivity resistant composition and application thereof
10/09/2013CN103340867A Osthole-mixing ointment, preparation method and applications
10/09/2013CN103340865A Cetirizine hydrochloride tablet and preparation method thereof
1 ... 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 ... 1172